Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed Conditions
Clinical trial NCT01903109 · COMPLETED
Trial details
- NCT number
- NCT01903109
- Sponsor
- Roxane Laboratories
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2009-02-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.